367 related articles for article (PubMed ID: 27124922)
1. Neuroendocrine Differentiation in Thymic Carcinomas: A Diagnostic Pitfall: An Immunohistochemical Analysis of 27 Cases.
Weissferdt A; Moran CA
Am J Clin Pathol; 2016 Mar; 145(3):393-400. PubMed ID: 27124922
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of thymic epithelial markers CD205 (DEC205) and Foxn1 in thymic epithelial neoplasms.
Nonaka D; Henley JD; Chiriboga L; Yee H
Am J Surg Pathol; 2007 Jul; 31(7):1038-44. PubMed ID: 17592270
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine differentiation in thymic epithelial tumors with special reference to thymic carcinoma and atypical thymoma.
Hishima T; Fukayama M; Hayashi Y; Fujii T; Arai K; Shiozawa Y; Funata N; Koike M
Hum Pathol; 1998 Apr; 29(4):330-8. PubMed ID: 9563781
[TBL] [Abstract][Full Text] [Related]
4. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9.5) in diagnosis and prognosis of neuroendocrine pulmonary tumours.
Kasprzak A; Zabel M; Biczysko W
Pol J Pathol; 2007; 58(1):23-33. PubMed ID: 17585539
[TBL] [Abstract][Full Text] [Related]
5. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
6. Thymic neuroendocrine tumors (paraganglioma and carcinoid tumors): a comparative immunohistochemical study of 46 cases.
Weissferdt A; Kalhor N; Liu H; Rodriguez J; Fujimoto J; Tang X; Wistuba II; Moran CA
Hum Pathol; 2014 Dec; 45(12):2463-70. PubMed ID: 25294372
[TBL] [Abstract][Full Text] [Related]
7. Frequent presence of neuroendocrine small cells in thymic carcinoma: a light microscopic and immunohistochemical study.
Kuo TT
Histopathology; 2000 Jul; 37(1):19-26. PubMed ID: 10931214
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of neuroendocrine carcinomas of the uterine cervix, including histopathologic features, terminology, immunohistochemical profile, and clinical outcomes in a series of 50 cases from a single institution in India.
Rekhi B; Patil B; Deodhar KK; Maheshwari A; A Kerkar R; Gupta S; Tongaonkar HB; Shrivastava SK
Ann Diagn Pathol; 2013 Feb; 17(1):1-9. PubMed ID: 22534245
[TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
[No Abstract] [Full Text] [Related]
11. Desmoglein 3 and p40 immunoreactivity in neoplastic and nonneoplastic thymus: a potential adjunct to help resolve selected diagnostic and staging problems.
Walts AE; Hiroshima K; Marchevsky AM
Ann Diagn Pathol; 2015 Aug; 19(4):216-20. PubMed ID: 25979154
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall.
Bahrami A; Gown AM; Baird GS; Hicks MJ; Folpe AL
Mod Pathol; 2008 Jul; 21(7):795-806. PubMed ID: 18487991
[TBL] [Abstract][Full Text] [Related]
13. Primary Neuroendocrine Tumors of the Ureter: A Short Review.
Acosta AM; Kajdacsy-Balla A
Arch Pathol Lab Med; 2016 Jul; 140(7):714-7. PubMed ID: 27362572
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical staining for bcl-2 and mcl-1 in intrathyroidal epithelial thymoma (ITET)/carcinoma showing thymus-like differentiation (CASTLE) and cervical thymic carcinoma.
Dorfman DM; Shahsafaei A; Miyauchi A
Mod Pathol; 1998 Oct; 11(10):989-94. PubMed ID: 9796728
[TBL] [Abstract][Full Text] [Related]
15. Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinoma.
Kashima J; Hashimoto T; Yoshida A; Goto Y; Ushiku T; Ohe Y; Watanabe SI; Yatabe Y
Virchows Arch; 2022 Dec; 481(6):893-901. PubMed ID: 36305944
[TBL] [Abstract][Full Text] [Related]
16. INSM1 Demonstrates Superior Performance to the Individual and Combined Use of Synaptophysin, Chromogranin and CD56 for Diagnosing Neuroendocrine Tumors of the Thoracic Cavity.
Rooper LM; Sharma R; Li QK; Illei PB; Westra WH
Am J Surg Pathol; 2017 Nov; 41(11):1561-1569. PubMed ID: 28719469
[TBL] [Abstract][Full Text] [Related]
17. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
McCluggage WG; Kennedy K; Busam KJ
Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
[TBL] [Abstract][Full Text] [Related]
18. Spindle cell thymomas: an immunohistochemical study of 30 cases.
Weissferdt A; Hernandez JC; Kalhor N; Moran CA
Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):329-35. PubMed ID: 21386704
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of tumour size in completely resected thymic epithelial tumours.
Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
Eur J Cardiothorac Surg; 2016 Dec; 50(6):1068-1074. PubMed ID: 27999073
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine differentiation is a common feature of thymic carcinoma.
Lauriola L; Erlandson RA; Rosai J
Am J Surg Pathol; 1998 Sep; 22(9):1059-66. PubMed ID: 9737237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]